What is the appropriate diagnostic and treatment approach for a 54-year-old male with microcytic hypochromic anemia, low MCV, low MCH, and a hemoglobin level of 118?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Microcytic Hypochromic Anemia in a 54-Year-Old Male

Order serum ferritin and transferrin saturation immediately, as these are the most specific tests to confirm iron deficiency anemia, which is the most likely diagnosis in this patient with low MCV and low MCH. 1

Diagnostic Workup

Initial Laboratory Tests

Obtain the following tests to establish the diagnosis:

  • Serum ferritin: A level <30 μg/L confirms iron deficiency in the absence of inflammation, while <15 μg/L indicates absent iron stores 1
  • Transferrin saturation (TSAT): A level <16-20% supports iron deficiency and is less affected by inflammation than ferritin 1, 2
  • Red cell distribution width (RDW): A low MCV with RDW >14.0% strongly suggests iron deficiency anemia, while RDW ≤14.0% suggests thalassemia minor 1
  • C-reactive protein (CRP): Essential to interpret ferritin correctly, as ferritin can be falsely elevated by inflammation up to 100 μg/L despite true iron deficiency 1
  • Reticulocyte count: A low count indicates impaired erythropoiesis, while elevated count suggests increased red cell production 2

Critical Interpretation Points

If ferritin is 30-100 μg/L with elevated CRP, iron deficiency may still be present—add TSAT to confirm the diagnosis. 1 A TSAT <20% with ferritin >100 μg/L indicates anemia of chronic disease rather than iron deficiency. 1

If ferritin is >100 μg/L, iron deficiency is almost certainly not present, and you should consider alternative diagnoses. 1

Treatment Algorithm

First-Line Treatment for Confirmed Iron Deficiency

Start oral ferrous sulfate 200 mg three times daily for at least three months after hemoglobin correction to replenish iron stores. 1 Alternative formulations include ferrous gluconate or ferrous fumarate if ferrous sulfate is not tolerated. 1

Add ascorbic acid (vitamin C) to enhance iron absorption. 1

Expected Response and Monitoring

Hemoglobin should rise ≥10 g/L within 2 weeks if iron deficiency is the cause. 1 If this response occurs, it confirms the diagnosis of iron deficiency anemia. 1

Monitor hemoglobin concentration and red cell indices at three-monthly intervals for one year, then after a further year. 1

Management of Treatment Failure

If the patient fails to respond to oral iron within 2-4 weeks, consider the following causes:

  • Non-compliance with medication 1
  • Ongoing blood loss (most common in adult males) 1
  • Malabsorption disorders (celiac disease, H. pylori infection, autoimmune atrophic gastritis) 1
  • True intolerance to oral preparations 1

For confirmed malabsorption, switch to intravenous iron (iron sucrose or iron gluconate), which should increase hemoglobin by at least 2 g/dL within 4 weeks. 1

Investigation of Underlying Cause

Mandatory Evaluation in Adult Males

All adult men with confirmed iron deficiency require investigation for gastrointestinal blood loss, as this is the most common cause in this population. 1 This is a critical step that should never be skipped.

Perform the following investigations:

  • Upper GI endoscopy with small bowel biopsies to rule out celiac disease (present in 2-3% of iron deficiency anemia patients) and other upper GI sources of bleeding 1
  • Colonoscopy to rule out colonic cancer, polyps, and angiodysplasia, particularly in patients over 50 years old 1

Men with hemoglobin <110 g/L warrant fast-track GI referral. 1

Differential Diagnosis Considerations

When to Consider Alternative Diagnoses

If iron studies are normal (ferritin >30 μg/L and TSAT >20%), order hemoglobin electrophoresis to evaluate for thalassemia trait, especially if:

  • MCV is disproportionately low relative to the degree of anemia 1
  • RDW is normal or near normal 1
  • Patient has appropriate ethnic background (Mediterranean, Asian, African descent) 1

Consider rare genetic disorders if:

  • Extreme microcytosis (MCV <70 fL) is present 1
  • Family history of refractory anemia exists 1
  • Patient fails to respond to both oral and intravenous iron 1

Rare Genetic Causes to Consider

IRIDA (Iron-Refractory Iron Deficiency Anemia) should be suspected if there is remarkably low TSAT with low-to-normal ferritin and failure to respond to oral iron but potential response to IV iron. 1

X-linked sideroblastic anemia (ALAS2 defects) can be treated with pyridoxine (vitamin B6) 50-200 mg daily initially, then 10-100 mg daily lifelong if responsive. 1

Critical Pitfalls to Avoid

Do not assume all microcytic anemia is iron deficiency—anemia of chronic disease, thalassemia, and sideroblastic anemia require different management. 1

Do not use ferritin alone in inflammatory states, as it can be falsely elevated by inflammation—always add TSAT to the diagnostic workup. 1

Do not overlook combined deficiencies—iron deficiency can coexist with B12 or folate deficiency, recognizable by elevated RDW. 1

Always investigate the source of iron loss in adult males with confirmed iron deficiency, as gastrointestinal malignancy must be excluded. 1

References

Guideline

Management of Microcytic Hypochromic Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Anemia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.